Adjuvant chemotherapy may contribute to an increased risk for metabolic syndrome in patients with breast cancer

Conclusions Adjuvant chemotherapy may contribute to an increased risk for metabolic syndrome in patients with BC and these changes are more profound in pre-menopausal patients.

http://opp.sagepub.com/cgi/content/abstract/22/1/46?rss=1

Source: Journal of Oncology Pharmacy Practice - December 15, 2015 Category: Cancer & Oncology Authors: Bicakli, D. H., Varol, U., Degirmenci, M., Tunali, D., Cakar, B., Durusoy, R., Karaca, B., Ali Sanli, U., Uslu, R. Tags: Original Articles Source Type: research